Dedicated to Solutions
Pharming’s intellectual property portfolio contributes to Pharming’s leading role as a player in the field of the production of recombinant proteins in transgenic animals.
With validation secured from the approval of our first product based on our transgenic platform, we now seek to initiate new projects on this platform.
Pharming is involved in the production, purification, formulation and development of recombinant protein products.
We take our obligation to behave in a sustainable, safe and responsible manner very seriously.
Pharming develops products for various applications in humans. In this section of the website you can find information on all of our products.
1st half year 2016 results(All Day: thursday)
All Day (thursday)
Q3 2016 results(All Day: thursday)